Koers BrainsWay Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
BWAY
IL0011007189
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 37,78 mln. 144 mln. 35,33 mln. | Omzet 2025 * | 44,04 mln. 168 mln. 41,19 mln. | Marktkapitalisatie | 83,45 mln. 318 mln. 78,05 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 0 | Nettowinst (verlies) 2025 * | 2 mln. 7,61 mln. 1,87 mln. | EV/omzet 2024 * | 2,21 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,9 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,14% |
Recentste transcriptie over BrainsWay Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hadar Levy
CEO | Chief Executive Officer | 52 | 14-09-14 |
Yiftach Roth
FOU | Founder | 54 | 01-05-06 |
David Zacut
FOU | Founder | 72 | 07-11-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Josef Ben Shalom
BRD | Director/Board Member | 68 | 01-12-18 |
Karen Sarid
BRD | Director/Board Member | 73 | 03-12-17 |
Amiram Boehm
CHM | Chairman | 52 | 12-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,07% | 218 mld. | |
+6,59% | 182 mld. | |
+11,26% | 132 mld. | |
+26,57% | 108 mld. | |
+13,35% | 52,98 mld. | |
-0,62% | 47,59 mld. | |
-0,93% | 39,96 mld. | |
+11,54% | 39,22 mld. | |
+26,76% | 26,94 mld. |